We are live on
!
Find out more
BCM
Bronte Capital Management Portfolio holdings
AUM
$1.01B
1-Year Est. Return
47.99%
This Fund
S&P 500
This Quarter
Est. Return
+13.86%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
–
AUM
$633M
AUM Growth
+$65M
(+11%)
Cap. Flow
-$64.3M
Cap. Flow
% of AUM
-10.16%
Top 10 Holdings %
Top 10 Hldgs %
90.65%
Holding
15
New
2
Increased
1
Reduced
7
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$10.3M |
| 2 |
Graham Holdings Company
GHC
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$58.2M |
| 2 |
Visa
V
|
+$17.5M |
| 3 |
Newmont
NEM
|
+$3.03M |
| 4 |
Interactive Brokers
IBKR
|
+$851K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$823K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 47.46% |
| 2 | Consumer Staples | 15.65% |
| 3 | Materials | 8.25% |
| 4 | Communication Services | 7.19% |
| 5 | Healthcare | 2.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class B
BRK.B
$1.1T
| $114M | 18% |
491,444
-3,739
| -0.8% | -$823K |
|
2
Herbalife
HLF
$1.29B
| $99M | 15.65% |
2,061,245
| – | – |
|
|
3
Interactive Brokers
IBKR
$39.2B
| $78.5M | 12.41% |
5,156,964
-64,220
| -1% | -$851K |
|
|
4
Visa
V
$684B
| $68.3M | 10.8% |
312,438
-85,519
| -21% | -$17.5M |
|
5
CALL
iShares Russell 2000 ETF
IWM
$79.8B
| $59.2M | 9.36% |
+30,000
| New | +$5.25M |
|
6
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $56.3M | 8.9% |
15,000
| – | – |
|
7
Corteva
CTVA
$52.6B
| $32.4M | 5.11% |
835,714
| – | – |
|
|
8
Alphabet (Google) Class C
GOOG
$4.36T
| $23.5M | 3.71% |
289,800
| – | – |
|
|
9
Alphabet (Google) Class A
GOOGL
$4.36T
| $22M | 3.48% |
251,720
-692,240
| -73% | -$58.2M |
|
|
BNY
10
Bank of New York Mellon
BNY
$106B
| $20.4M | 3.22% |
480,315
-9,770
| -2% | -$375K |
|
|
11
Newmont
NEM
$98.7B
| $19.9M | 3.14% |
331,769
-49,134
| -13% | -$3.03M |
|
12
State Street
STT
$50.6B
| $19.2M | 3.03% |
263,537
-7,489
| -3% | -$508K |
|
|
13
Regeneron Pharmaceuticals
REGN
$78.5B
| $9.21M | 1.45% |
+19,053
| New | +$10.3M |
|
|
14
Graham Holdings Company
GHC
$5.1B
| $7.25M | 1.15% |
13,588
+3,417
| +34% | +$1.51M |
|
|
MACK
15
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $3.66M | 0.58% |
531,510
| – | – |
|
Similar funds
EPAM
AG
GA
CT
AH
PIM
WA
MIM
Bronte Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Bronte Capital Management held 15 positions worth $633M, up 11% from $568M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Bronte Capital Management withdrew a net $64.3M in Q4 2020, reducing 7 holdings. Its largest reduction was Alphabet (Google) Class A, cutting an estimated $58.2M.
By sector, the portfolio is most concentrated in Financials at 47% of assets, up from 47% a quarter earlier, followed by Consumer Staples and Materials.
Against the trend, Bronte Capital Management opened a new position in Regeneron Pharmaceuticals worth $9.21M.
- Bronte Capital Management's largest Q4 2020 buy was Regeneron Pharmaceuticals: 19,053 shares worth $9.21M.
- Bronte Capital Management added most to Graham Holdings Company in Q4 2020, an estimated $1.51M increase.
- Bronte Capital Management's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $58.2M.
- Bronte Capital Management's ten largest holdings make up 91% of its $633M portfolio in Q4 2020.
- Bronte Capital Management opened 2 new positions and closed 0 in Q4 2020.
- Bronte Capital Management's portfolio value rose 11% quarter-over-quarter to $633M.
Based on Bronte Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.